Statements (60)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:genus
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Mycobacterium_tuberculosis
|
| gptkbp:caused_by |
leprosy
tuberculosis |
| gptkbp:communication |
airborne droplets
|
| gptkbp:house |
mycolic acids
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mycobacterium
|
| gptkbp:is_a |
gptkb:physicist
|
| gptkbp:is_aimed_at |
antitubercular drugs
|
| gptkbp:is_associated_with |
weight loss
fever night sweats chronic cough immunocompromised individuals respiratory symptoms pulmonary disease |
| gptkbp:is_characterized_by |
acid-fastness
non-motility high lipid content slow doubling time |
| gptkbp:is_found_in |
gptkb:garden
gptkb:item human hosts |
| gptkbp:is_involved_in |
public health initiatives
host-pathogen interactions chronic infections |
| gptkbp:is_known_for |
complex life cycle
slow growth rate pathogenic mechanisms form biofilms evade immune response chronic granulomatous inflammation intracellular survival |
| gptkbp:is_part_of |
infectious diseases
clinical microbiology infectious disease research human microbiome Actinobacteria phylum |
| gptkbp:is_recognized_by |
Ziehl-Neelsen stain
|
| gptkbp:is_related_to |
Corynebacterium
Nocardia |
| gptkbp:is_studied_in |
molecular biology
genetic diversity public health microbiology epidemiology vaccine efficacy pathogenicity vaccine development strategies |
| gptkbp:is_used_in |
gptkb:Company
diagnostic tests vaccine development research on antibiotic resistance |
| gptkbp:is_vulnerable_to |
disinfectants
many antibiotics |
| gptkbp:species |
gptkb:Mycobacterium_bovis
gptkb:Mycobacterium_tuberculosis Mycobacterium leprae Mycobacterium avium |